1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium)

C230H214Ir4N12O5SSi4-8 — CID 163531110

IUPAC1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium)
SMILESCC(C)(C)c1cc(-c2ccccc2)c(-n2c(-c3[c-]ccc4c3oc3ccccc34)nc3ccccc32)c(-c2ccccc2)c1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.[Ir].[Ir].[Ir].[Ir].[c-]1ccc2c(oc3ccccc32)c1-c1nc2ccccc2n1-c1c(-c2ccccc2)ccc2ccccc12.[c-]1ccc2c(oc3ccccc32)c1-c1nc2ccccc2n1-c1ccc2sc3ccccc3c2c1.[c-]1ccc2c(oc3ccccc32)c1-c1nc2ccccc2n1-c1cccc2c1oc1ccccc12
InChIInChI=1S/C41H31N2O.C35H21N2O.C31H17N2O2.C31H17N2OS.4C23H32NSi.4Ir/c1-41(2,3)29-25-33(27-15-6-4-7-16-27)38(34(26-29)28-17-8-5-9-18-28)43-36-23-12-11-22-35(36)42-40(43)32-21-14-20-31-30-19-10-13-24-37(30)44-39(31)32;1-2-11-23(12-3-1)26-22-21-24-13-4-5-14-25(24)33(26)37-31-19-8-7-18-30(31)36-35(37)29-17-10-16-28-27-15-6-9-20-32(27)38-34(28)29;1-5-17-27-19(9-1)21-11-7-13-23(29(21)34-27)31-32-24-14-3-4-15-25(24)33(31)26-16-8-12-22-20-10-2-6-18-28(20)35-30(22)26;1-5-14-27-20(8-1)22-10-7-11-23(30(22)34-27)31-32-25-12-3-4-13-26(25)33(31)19-16-17-29-24(18-19)21-9-2-6-15-28(21)35-29;4*1-17(2)19-10-12-20(13-11-19)22-15-21(14-18-8-6-7-9-18)23(16-24-22)25(3,4)5;;;;/h4-20,22-26H,1-3H3;1-16,18-22H;1-12,14-18H;1-10,12-18H;4*10-12,15-18H,6-9,14H2,1-5H3;;;;/q8*-1;;;;
InChIKeyZMNFNLKKIJJUMB-UHFFFAOYSA-N
MW4139.60 g/mol
LogP61.08
Rot. Bonds31

About 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium)

1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium) (PubChem CID 163531110) has the molecular formula C230H214Ir4N12O5SSi4-8 and a molecular weight of 4139.60 g/mol. Its IUPAC name is 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium).

Molecular Properties

Compound Name1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium)
PubChem CID163531110
Molecular FormulaC230H214Ir4N12O5SSi4-8
Molecular Weight4139.60 g/mol
Exact Mass4139.42
IUPAC Name1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium)
SMILESCC(C)(C)c1cc(-c2ccccc2)c(-n2c(-c3[c-]ccc4c3oc3ccccc34)nc3ccccc32)c(-c2ccccc2)c1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.[Ir].[Ir].[Ir].[Ir].[c-]1ccc2c(oc3ccccc32)c1-c1nc2ccccc2n1-c1c(-c2ccccc2)ccc2ccccc12.[c-]1ccc2c(oc3ccccc32)c1-c1nc2ccccc2n1-c1ccc2sc3ccccc3c2c1.[c-]1ccc2c(oc3ccccc32)c1-c1nc2ccccc2n1-c1cccc2c1oc1ccccc12
InChIInChI=1S/C41H31N2O.C35H21N2O.C31H17N2O2.C31H17N2OS.4C23H32NSi.4Ir/c1-41(2,3)29-25-33(27-15-6-4-7-16-27)38(34(26-29)28-17-8-5-9-18-28)43-36-23-12-11-22-35(36)42-40(43)32-21-14-20-31-30-19-10-13-24-37(30)44-39(31)32;1-2-11-23(12-3-1)26-22-21-24-13-4-5-14-25(24)33(26)37-31-19-8-7-18-30(31)36-35(37)29-17-10-16-28-27-15-6-9-20-32(27)38-34(28)29;1-5-17-27-19(9-1)21-11-7-13-23(29(21)34-27)31-32-24-14-3-4-15-25(24)33(31)26-16-8-12-22-20-10-2-6-18-28(20)35-30(22)26;1-5-14-27-20(8-1)22-10-7-11-23(30(22)34-27)31-32-25-12-3-4-13-26(25)33(31)19-16-17-29-24(18-19)21-9-2-6-15-28(21)35-29;4*1-17(2)19-10-12-20(13-11-19)22-15-21(14-18-8-6-7-9-18)23(16-24-22)25(3,4)5;;;;/h4-20,22-26H,1-3H3;1-16,18-22H;1-12,14-18H;1-10,12-18H;4*10-12,15-18H,6-9,14H2,1-5H3;;;;/q8*-1;;;;
InChIKeyZMNFNLKKIJJUMB-UHFFFAOYSA-N
XLogP61.08
TPSA188.54 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds31
Heavy Atoms256
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5004139.60
LogP ≤ 561.08
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium)?
The IUPAC name of 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium) (CID 163531110) is 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium).
What is the SMILES notation for 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium)?
The canonical SMILES for 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium) is CC(C)(C)c1cc(-c2ccccc2)c(-n2c(-c3[c-]ccc4c3oc3ccccc34)nc3ccccc32)c(-c2ccccc2)c1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.CC(C)c1c[c-]c(-c2cc(CC3CCCC3)c([Si](C)(C)C)cn2)cc1.[Ir].[Ir].[Ir].[Ir].[c-]1ccc2c(oc3ccccc32)c1-c1nc2ccccc2n1-c1c(-c2ccccc2)ccc2ccccc12.[c-]1ccc2c(oc3ccccc32)c1-c1nc2ccccc2n1-c1ccc2sc3ccccc3c2c1.[c-]1ccc2c(oc3ccccc32)c1-c1nc2ccccc2n1-c1cccc2c1oc1ccccc12.
What is the InChIKey of 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium)?
The InChIKey is ZMNFNLKKIJJUMB-UHFFFAOYSA-N. The full InChI is InChI=1S/C41H31N2O.C35H21N2O.C31H17N2O2.C31H17N2OS.4C23H32NSi.4Ir/c1-41(2,3)29-25-33(27-15-6-4-7-16-27)38(34(26-29)28-17-8-5-9-18-28)43-36-23-12-11-22-35(36)42-40(43)32-21-14-20-31-30-19-10-13-24-37(30)44-39(31)32;1-2-11-23(12-3-1)26-22-21-24-13-4-5-14-25(24)33(26)37-31-19-8-7-18-30(31)36-35(37)29-17-10-16-28-27-15-6-9-20-32(27)38-34(28)29;1-5-17-27-19(9-1)21-11-7-13-23(29(21)34-27)31-32-24-14-3-4-15-25(24)33(31)26-16-8-12-22-20-10-2-6-18-28(20)35-30(22)26;1-5-14-27-20(8-1)22-10-7-11-23(30(22)34-27)31-32-25-12-3-4-13-26(25)33(31)19-16-17-29-24(18-19)21-9-2-6-15-28(21)35-29;4*1-17(2)19-10-12-20(13-11-19)22-15-21(14-18-8-6-7-9-18)23(16-24-22)25(3,4)5;;;;/h4-20,22-26H,1-3H3;1-16,18-22H;1-12,14-18H;1-10,12-18H;4*10-12,15-18H,6-9,14H2,1-5H3;;;;/q8*-1;;;;.
What are the key properties of 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium)?
1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium) has a molecular weight of 4139.60 g/mol, XLogP of 61.08, 31 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(4-tert-butyl-2,6-diphenylphenyl)-2-(3H-dibenzofuran-3-id-4-yl)benzimidazole;tetrakis([4-(cyclopentylmethyl)-6-(4-propan-2-ylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzofuran-4-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-dibenzothiophen-2-ylbenzimidazole;2-(3H-dibenzofuran-3-id-4-yl)-1-(2-phenylnaphthalen-1-yl)benzimidazole;tetrakis(iridium) is sourced from PubChem (CID 163531110), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).